Solventum Corp Files 8-K

TL;DR

Solventum Corp (formerly 3M Health Care) filed its 8-K on 9/8/25. All systems go.

AI Summary

Solventum Corporation, formerly 3M Health Care Co, filed an 8-K on September 8, 2025. The filing indicates the company is incorporated in Delaware and has its principal executive offices at 3M Center, Building 275-6W, East, Maplewood, Minnesota. The filing is related to 'Other Events' and 'Financial Statements and Exhibits'.

Why It Matters

This filing provides official corporate information for Solventum Corporation, a newly independent entity, which is crucial for investors and stakeholders to track its regulatory compliance and corporate structure.

Risk Assessment

Risk Level: low — This is a routine corporate filing providing basic information and does not indicate any immediate financial or operational risks.

Key Numbers

• 001-41968 — SEC File Number (Identifies the company's filing history with the SEC.)
• 92-2008841 — IRS Employer Identification No. (Unique tax identification number for the company.)

Key Players & Entities

• Solventum Corporation (company) — Registrant
• 3M Health Care Co (company) — Former Name
• 3M Company (company) — Associated Company (address)
• September 8, 2025 (date) — Date of Report
• Delaware (jurisdiction) — State of Incorporation
• Maplewood, Minnesota (location) — Principal Executive Offices

FAQ

From the Filing

0001964738-25-000084.txt : 20250908 0001964738-25-000084.hdr.sgml : 20250908 20250908163544 ACCESSION NUMBER: 0001964738-25-000084 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20250908 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250908 DATE AS OF CHANGE: 20250908 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Solventum Corp CENTRAL INDEX KEY: 0001964738 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 922008841 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41968 FILM NUMBER: 251300493 BUSINESS ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 BUSINESS PHONE: 651-733-1110 MAIL ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 FORMER COMPANY: FORMER CONFORMED NAME: 3M Health Care Co DATE OF NAME CHANGE: 20230203 8-K 1 solv-20250908.htm 8-K solv-20250908 FALSE 0001964738 0001964738 2025-09-08 2025-09-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 8, 2025 SOLVENTUM CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware File No. 001-41968 92-2008841 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 3M Center, Building 275-6W 2510 Conway Avenue East , Maplewood , Minnesota 55144 (Address of Principal Executive Offices) (Zip Code) (Registrant’s Telephone Number, Including Area Code) ( 651 ) 733-1110 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $.01 Per Share SOLV New York Stock Exchange Securities registered pursuant to section 12(g) of the Act: None Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company      ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the exchange Act.     ☐ Item 8.01. Other Events. Results and Upsizing of Note Tender Offers On September 8, 2025, Solventum Corporation (the “Company”) issued a press release announcing the results as of the early participation date and upsizing of its previously announced cash tender offers to purchase certain of its outstanding debt securities (the “Tender Offers”). A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 8.01 by reference. Pricing of Note Tender Offers On September 8, 2025, the Company issued a press rel